During the past decade, National Hospital Organization Yokohama Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Yokohama Medical Center" #1 sponsor was "Pfizer" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "CG Oncology, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Yokohama Medical Center" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Yokohama Medical Center" are "Psoriasis" (2 trials), "Complicated Intra-abdominal Infection" (1 trials), "Deep Vein Thrombosis" (1 trials), "Gastroesophageal Reflux Disease" (1 trials) and "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials). Many other conditions were trialed in "National Hospital Organization Yokohama Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Yokohama Medical Center" are "Drug" (9 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "BMS-986165" (2 trials), "Apixaban" (1 trials), "Apremilast" (1 trials) and "CG0070" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Yokohama Medical Center" are 11 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Yokohama Medical Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in National Hospital Organization Yokohama Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Yokohama Medical Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".